Home › Chronic Lymphocytic Leukemia › Oregon › Portland

Pag-aaral pangklinika para sa Chronic Lymphocytic Leukemia sa Portland, OR

Isang pag-aaral para sa Chronic Lymphocytic Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Portland. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

Nagre-recruitPhase 3

Oregon Health and Science University ( Site 5425), Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05947851

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Nagre-recruitPhase 3

Providence Portland Medical Center, Portland
Providence Saint Vincent Medical Center, Portland

Edad 65 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07321652

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Providence Portland Medical Center, Portland
Providence Saint Vincent Medical Center, Portland
Providence Willamette Falls Medical Center, Oregon City · 12 mi ang layo

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Nagre-recruitPhase 3

Providence Portland Medical Center, Portland
Providence Saint Vincent Medical Center, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT04269902

Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment

Nagre-recruitObservasyonal na pag-aaral

OHSU Knight Cancer Institute, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06784167

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

Nagre-recruitPhase 1/2

Research Site, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06564038

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Nagre-recruitPhase 1/2

Oregon Health & Science University, Portland

Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06533579

Study of SGR-1505 in Mature B-Cell Neoplasms

Nagre-recruitPhase 1

Oregon Health and Science University - Knight Cancer Institute, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT05544019

Tafasitamab, Acalabrutinib, and Obinutuzumab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Nagre-recruitPhase 1

OHSU Knight Cancer Institute, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2025 · NCT05943496

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Nagre-recruitPhase 1

Oregon Health & Science University, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2025 · NCT05780034

Pag-aaral para sa Chronic Lymphocytic Leukemia sa ibang lungsod

Iba pang pag-aaral sa Portland

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.